Convertible Bridge Loan Sample Clauses
POPULAR SAMPLE Copied 1 times
Convertible Bridge Loan. Upon approval of this Agreement by the Board ----------------------- and receipt of the opinion of counsel referenced in paragraph 12, ▇▇▇▇ shall make a bridge loan to the Company in the principal amount of $200,000 evidenced by a promissory note ("Bridge Loan"). The principal amount of the Bridge Loan shall bear interest at the rate of 10% per annum and shall be due and payable on July 1, 2000. The principal amount and all accrued interest under the Bridge Loan may, at the election of ▇▇▇▇, be applied toward the purchase of Series A Preferred stock, or, in the event of the failure of a Specified Condition described in paragraph 1(g) below, may, at the election of ▇▇▇▇, be applied toward the purchase of Common Stock in accordance with the terms of such paragraph 1(g).
Convertible Bridge Loan. 1. Subject to subject to the terms and conditions of this Agreement, the Investors grant to the Company a loan in the amount of Euro 2,000,000 which shall be convertible into shares of the Company, subject to the terms and conditions of this Agreement (the “Convertible Bridge Loan”).
2. The principal amount of the Convertible Bridge Loan shall be divided between the Investors as follows (individually a “Loan Amount” and collectively, the “Loan Amounts”): Orbimed Private Investments III, LP 492.113 Orbimed Associates III, LLC 4.687 Novo Nordisk A/S 199.606 Transconnect Corporate Finance Beratungs GmbH 50.285 BioM AG 164.751 BioM Venture Capital GmbH & Co. KG 0 The Global Life Science Ventures Fonds II GmbH & Co. KG 252.173 The Global Life Science Ventures Fund II LP 196.145 Gilde Europe Food & Agribusiness Fund B.V. 421.015 Baytech Venture ▇▇▇▇▇▇▇ ▇▇▇▇ & ▇▇. ▇▇ ▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇ LS U.A. 219.225 KfW 0 Technologie Beteiligungsfonds II Bayern GmbH & Co. KG (BayernKapital) 0
3. All Shareholders hereby expressly consent to the distribution of the principal amount of the Convertible Bridge Loan among the Investors pursuant to para. (2) of this Sec. 1 and waive any subscription rights or similar rights in relation to the Convertible Bridge Loan.
4. The Loan Amounts shall be paid out by the Investors to the Company within ten (10) bank working days in Frankfurt/Main, Germany, after the closing of this Agreement to an account submitted by the Company to the Investors in writing.
Convertible Bridge Loan. The Convertible Bridge ----------------------- Loan shall consist of a term loan from FINOVA to Borrowers in the aggregate amount of $40,000,000. FINOVA shall disburse the proceeds of the Convertible Bridge Loan to or as directed by Borrowers when all of the terms and conditions set forth in Paragraph 3 of the First Amendment have been satisfied."
Convertible Bridge Loan. The Principal Balance of the ----------------------- Convertible Bridge Loan shall be due and payable on the Initial CBL Maturity Date; provided, however, in the event InfoCure shall not have consummated an Offering on or before the Initial CBL Maturity Date the net proceeds of which shall have been sufficient to repay in full the Principal Balance of the Convertible Bridge Loan on the Initial CBL Maturity Date in accordance with subsection 2.6.2(b), then the Principal Balance of the Convertible Bridge Loan (after giving effect to any repayments thereof required to be made under subsection 2.6.2(b) and subsection 2.6.2(c)) shall be payable in fifteen (15) consecutive quarterly installments on the first Business Day of each quarter commencing with the first Business Day of the quarter immediately succeeding the quarter in which the Initial CBL Maturity Date occurs. Each such installment shall be in an amount equal to the applicable percentage of the Principal Balance of the Convertible Bridge Loan on the Initial CBL Maturity Date (after giving effect to any repayments thereof required to be made under subsection 2.6.2(b) and subsection 2.6.2(c)) as set forth below: Installment Percentage ----------- ---------- 1 through 4 2.5% 5 through 12 5.0% 13 through 14 10.0% 15 Then Remaining Principal Balance"
(xii) Section 2.4. Section 2.4 of the Existing Loan Agreement is amended ----------- by adding the following subsection 2.4.4 to such Section 2.4 in the appropriate numerical order:
Convertible Bridge Loan the term loan in the aggregate amount of ----------------------- $40,000,000 to be made by FINOVA to Borrowers pursuant to subsection 2.1.3 of this Loan Agreement.
Convertible Bridge Loan. 1. Subject to the terms and conditions of this Agreement, the Investors grant to the Company a loan in the amount of up to Euro 2,000,000 which may be convertible into shares of the Company as provided in this Agreement and is divided into (i) a tranche A of EUR 1,500,000 and (ii) a tranche B of up to EUR 500,000 (the “Convertible Bridge Loan”).
2. The principal amount of the Convertible Bridge Loan shall be allocated among the Investors as displayed in the table below (the portion of each Investor of the Convertible Bridge Loan a “Loan Amount” and, collectively, the “Loan Amounts”; each Investor’s pro rata portion of the Convertible Bridge Loan, based on his or its shareholding of Preferred Shares, insofar as such pro portion does not exceed his or its Loan Amount, a “Pro Rata Loan Amount” and, collectively, the “Pro Rata Loan Amounts”; the amount by which each Investor’s Loan Amount exceeds his Pro Rata Loan Amount, if applicable, a “Super Pro Rata Loan Amount” and, collectively, the “Super Pro Rata Loan Amounts”; and the portion of each Investor of the Tranche A and of the Tranche B a “Tranche A Loan Amount” and a “Tranche B Loan Amount”, respectively, and collectively, the “Tranche A Loan Amounts” and “Tranche B Loan Amounts”, respectively): Orbimed Private Investments III, LP 797.987 395.444 402.543 598.490 199.497 Orbimed Associates III, LLC 5.001 3.766 1.235 3.751 1.250 Novo Nordisk A/S 199.606 199.606 149.705 49.902 Transconnect Corporate Finance Beratungs GmbH 53.659 40.407 13.252 40.244 13.415 BioM AG 13.747 10.352 3.395 10.310 3.437 BioM Venture Capital GmbH & Co. KG 0 122.036 0 0 The Global Life Science Ventures Fonds II GmbH & Co. KG 168.746 202.637 126.560 42.197 The Global Life Science Ventures Fund II LP 131.254 157.614 98.440 32.813 Gilde Europe Food & Agribusiness Fund B.V. 300.000 360.249 225.000 75.000 Baytech Venture Capital GmbH & Co. KG 200.000 171.243 28.757 150.000 50.000 Coöperatieve AAC LS U.A. 130.000 219.225 97.500 32.500 KfW 0 73.935 0 0 Technologie Beteiligungsfonds II Bayern GmbH & Co. KG (BayernKapital) 0 43.485 0 0
Convertible Bridge Loan